ARTICLE | Company News
Orion, Recordati sales and marketing update
June 2, 2008 7:00 AM UTC
Recordati granted Orion exclusive rights to market Kentera oxybutynin transdermal patch to treat overactive bladder (OAB) in Nordic countries and Switzerland. Orion said it expects to launch Kentera i...